Clinical Trials
4 trialsNCT01824901 2023-06-29
Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Phase 1/2 Completed
NCT01791985 2022-08-22
RADICAL
Imperial College London
Phase 1/2 Completed
NCT05086666 2021-10-21
A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
Abbisko Therapeutics Co, Ltd
Phase 1/2 Unknown
NCT01202591 2016-02-11
GLOW
AstraZeneca
Phase 1/2 Completed